Skip to product information
1 of 1

ABCbiolab

SKU:ABCC24737

ELISA Kit for Glucose Transporter 2 (GLUT2)

ELISA Kit for Glucose Transporter 2 (GLUT2)

Regular price $760.00 USD
Regular price Sale price $760.00 USD
Sale Sold out
Shipping calculated at checkout.
UOM
Sensitivity
Host

Format

48T, 96T, 96T×5, 96T×10, 96T×100

Detection range

0.78-50ng/mL

Application

Enzyme-linked immunosorbent assay for Antigen Detection.

Organism species

Rattus norvegicus (Rat)

Sensitivity

The minimum detectable dose of this kit is typically less than 0.26ng/mL

Sample type

Tissue homogenates, cell lysates and other biological fluids

Assay length

3h

Method

Double-antibody Sandwich

Test principle

The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Glucose Transporter 2 (GLUT2). Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated antibody specific to Glucose Transporter 2 (GLUT2). Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Glucose Transporter 2 (GLUT2), biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Glucose Transporter 2 (GLUT2) in the samples is then determined by comparing the O.D. of the samples to the standard curve.

Alternative Names

SLC2A2; SLC2-A2; Solute carrier family 2, facilitated glucose transporter member 2; Glucose transporter type 2, liver

Item Name

Glucose Transporter 2

Research Area

Metabolic pathway;Endocrinology;Hepatology;

Reference

Topiramate-Induced Modulation of Hepatic Molecular Mechanisms: An Aspect for Its Anti-Insulin Resistant Effect;Antidiabetic Effect of Galantamine: Novel Effect for a Known Centrally Acting Drug;Oral formulation of DPP-4 inhibitor plus Quercetin improves metabolic homeostasis in type 1 diabetic rats;

View full details